Yu‐Ling Chang
Papers
1
Total Citations
73
H-Index
1
About
Yu-Ling Chang is a leading figure in thoracic surgical oncology, with a focused expertise in minimally invasive esophageal surgery and the optimization of radical lymph node dissection. Her major contribution lies in pioneering comparative effectiveness research between robotic-assisted and video-assisted thoracoscopic esophagectomy. Her most cited work, the REVATE trial protocol (2019, 73 citations), addresses a critical surgical challenge—performing safe, thorough lymphadenectomy along the left recurrent laryngeal nerve, a procedure notorious for high morbidity. By designing a randomized controlled trial to evaluate whether robotic assistance can reduce complications while maintaining oncologic rigor, Chang has directly shaped the evidence base for adopting robotic platforms in high-risk thoracic procedures. Her research bridges the gap between technological innovation and patient safety, offering surgeons a data-driven framework for improving postoperative outcomes. This work has positioned her as a key voice in the ongoing debate over optimal minimally invasive approaches for esophageal cancer, influencing both clinical practice and future trial design.
Research Focus
Key Achievements
Top Papers
- 1